Novavax (NVAX) Reports In-Line Q3 EPS
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $4.07 --0%
Revenue Growth %: +85.7%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
SFST, VLTO, CLIR, More
Revenue Growth %: +85.7%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $7.7 million versus the consensus estimate of $9.4 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan is worried about further S&P 500 sell-off potential
- SAP SE (SAP) Misses Q1 EPS by 25c; offers outlook
- Spotify (SPOT) jumps as Q1 print tops estimates on top and bottom lines
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
